ABL DiagnosticsXPAR:ABLD +0.76%51 Dividend Payout Ratio is 0.00 as of Dec. 2025. GuruFocus rates XPAR:ABLD with a GF Score™ of 51/100 and a GF Value™ of €7.71 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 248 Healthcare Providers & Services companies, ABL Diagnostics ranks worse than 85.48% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. ABL Diagnostics's Dividend Payout Ratio for the
months ended in Dec. 2025 was 0.00.
Warning Sign:
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of ABL Diagnostics is 0.82, which seems too high.
The historical rank and industry rank for ABL Diagnostics's Dividend Payout Ratio or its related term are showing as below:
XPAR:ABLD'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.81 Med: 0.81 Max: 0.82
Current: 0.82
During the past 13 years, the highest Dividend Payout Ratio of ABL Diagnostics was 0.82. The lowest was 0.81. And the median was 0.81.
XPAR:ABLD's Dividend Payout Ratio is ranked worse than 85.48% of 248
companies
in the Healthcare Providers & Services industry
Industry Median: 0.41
vs XPAR:ABLD: 0.82
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
ABL Diagnostics (XPAR:ABLD) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
ABL Diagnostics Dividend Payout Ratio Related Terms
ABL Diagnostics Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for ABL Diagnostics's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:ABLD vs VEEV, BTSG, TEM: Dividend Payout Ratio Comparison
For the Health Information Services subindustry, ABL Diagnostics's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ABL Diagnostics Dividend Payout Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ABL Diagnostics's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where ABL Diagnostics's Dividend Payout Ratio falls into.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
ABL Diagnostics's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ABL Diagnostics (XPAR:ABLD) has a Dividend Payout Ratio of 0.00 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on ABL Diagnostics and its competitors. Over the past decade, ABL Diagnostics' Dividend Payout Ratio has ranged from 0.81 to 0.82. According to the industry distribution chart, ABL Diagnostics ranks #212 out of 248 companies in the Healthcare Providers & Services industry, placing it in the top 85.5%.
Is ABL Diagnostics' Dividend Payout Ratio too high?
ABL Diagnostics' current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.81 to a high of 0.82. Based on the distribution chart, ABL Diagnostics ranks #212 out of 248 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, ABL Diagnostics has a GF Score™ of 51/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ABL Diagnostics' Dividend Payout Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, ABL Diagnostics ranks #212 out of 248 companies for Dividend Payout Ratio. This places ABL Diagnostics in the lower half of its industry. The industry median Dividend Payout Ratio is 0.41. Historically, ABL Diagnostics' own Dividend Payout Ratio has ranged from 0.81 to 0.82 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Healthcare Providers & Services company?
The median Dividend Payout Ratio among Healthcare Providers & Services companies is 0.41, based on 248 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on ABL Diagnostics and its competitors. For the Healthcare Providers & Services industry, the median Dividend Payout Ratio is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ABL Diagnostics's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ABL Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, ABL Diagnostics (XPAR:ABLD) is currently considered Significantly Undervalued. The stock's GF Value™ is €7.71, compared to a current price of €2.66 — trading 65.5% below its estimated fair value. The current Dividend Payout Ratio is 0.00. ABL Diagnostics' overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For ABL Diagnostics (XPAR:ABLD), the current Dividend Payout Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ABL Diagnostics (XPAR:ABLD) Overvalued in 2026?
Based on GuruFocus' analysis, ABL Diagnostics stock appears to be undervalued.
The current stock price of €2.66 is trading 65.5% below its estimated GF Value™ of €7.71.
GuruFocus considers ABL Diagnostics to be Significantly Undervalued.
Key valuation signals for XPAR:ABLD:
Dividend Payout Ratio: 0.00
GF Value™: €7.71 vs. price of €2.66 (65.5% below fair value)
No single metric tells the full story. See the XPAR:ABLD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.
51GF Score
Get the complete analysis for XPAR:ABLD
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ABLD has been successfully added to your 
